Finally, there are receptors in the lungs that detect the stretch that happens when they inflate and deflate. When you hold your breath and they stop stretching, alarm bells start to sound.

It's the first time that this missing receptor, called CCR2 ... underlies progressive polycystic lung disease, Cell (2023). DOI: 10.1016/j.cell.2023.11.036 ...

Non-small cell lung cancers account for about 85% of lung cancers, many of them associated with smoking. Of these, roughly 30 ...

Both these drugs target the epidermal growth factor receptor (EGFR), a protein ... that allows lung tumors to become resistant to drugs like lazertinib and osimertinib. Rybrevant, a major asset in J&J ...

The University of Cincinnati's Debanjan Bhattacharya is first author of new research published in Cancers that found the drug AM-101 improves the effectiveness and survival rate of radiation treatment ...

While women are thought to generally have greater protection than men against CVD due to estrogen, women have been shown to ...

The synthetic peptide was inspired by ACE2, the protein to which the virus that causes COVID-19 binds to invade human cells.

When breast cancer cells test positive for estrogen receptors, it’s called estrogen ... moved into lymph nodes or distant organs, like the lungs, bones, or brain. Research on survival statistics ...

Lung cancer is a major health concern in the Gulf Cooperation Council (GCC) countries, particularly Kuwait and Saudi ...

locally advanced or metastatic epidermal growth factor receptor (EGFR) wild type, nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression. Approximately 85% of lung ...

Semaglutide, the same compound that’s in Ozempic, is part of a class of medications known as glucagon-like peptide 1 (GLP-1) ...

The sBLA is supported by results from the phase IIIDESTINY-Breast06 trial (NCT04494425), which showed that patients with HER2 ...